Protein-protein interactions of ASPP2: an emerging therapeutic target

被引:8
|
作者
Iosub-Amir, Anat [1 ]
Friedler, Assaf [1 ]
机构
[1] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel
关键词
APOPTOSIS-STIMULATING PROTEIN; NF-KAPPA-B; MESSENGER-RNA EXPRESSION; TUMOR-SUPPRESSOR ASPP2; BCL-2 FAMILY PROTEINS; PROLINE-RICH-REGION; VIRUS CORE PROTEIN; CANCER-CELL-LINES; STRUCTURAL BASIS; PHOSPHATASE;
D O I
10.1039/c4md00147h
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pro-apoptotic ASPP2 protein plays a central role in regulating apoptosis in both p53-dependent and p53-independent pathways. It has become clear in recent years that ASPP2 plays also a role in other important cellular processes like senescence and regulating cell polarity. ASPP2 interacts with numerous proteins in order to exert its pro-apoptotic effect while some other proteins inhibit its pro-apoptotic activity. These interactions are emerging potential targets for activation or inhibition. Drugs that activate ASPP2 may not only induce apoptosis of cancer cells, but also affect other disease-related cellular pathways. Here we review the interactions of ASPP2 with its partner proteins and their potential targeting for drug development.
引用
收藏
页码:1435 / 1443
页数:9
相关论文
共 50 条
  • [1] Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2
    Rotem, S.
    Katz, C.
    Friedler, A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 966 - 969
  • [2] Emerging therapeutic opportunities by targeting protein-protein interactions
    Gonzalez-Muniz, Rosario
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (01) : 1 - 2
  • [3] Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities
    Yan, Yue
    Gong, Yiting
    Liang, Xiaohui
    Xiong, Qingyi
    Lin, Jiayi
    Wu, Ye
    Zhang, Lijun
    Chen, Hongzhuan
    Jin, Jinmei
    Luan, Xin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (01):
  • [4] Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax
    Patel, Seema
    George, Roger
    Autore, Flavia
    Fraternali, Franca
    Ladbury, John E.
    Nikolova, Penka V.
    NUCLEIC ACIDS RESEARCH, 2008, 36 (16) : 5139 - 5151
  • [5] Protein-protein interactions as a target for drugs in proteomics
    Archakov, AI
    Govorun, VM
    Dubanov, AV
    Ivanov, YD
    Veselovsky, AV
    Lewi, P
    Janssen, P
    PROTEOMICS, 2003, 3 (04) : 380 - 391
  • [6] Protein-protein interactions as therapeutic targets in neuropsychopharmacology
    Reilly, Matthew T.
    Cunningham, Kathryn A.
    Natarajan, Amarnath
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (01) : 247 - 248
  • [7] Diversity in protein-protein interactions of connexins:: emerging roles
    Hervé, JC
    Bourmeyster, N
    Sarrouilhe, D
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1662 (1-2): : 22 - 41
  • [8] Stretching Peptides' Potential to Target Protein-Protein Interactions
    Venneti, Naresh M.
    Stockdill, Jennifer L.
    ACS CENTRAL SCIENCE, 2023, 9 (04) : 590 - 592
  • [9] Therapeutic intervention targeting protein-protein interactions - Preface
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1373 - 1373
  • [10] Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development
    Zhang, Gan
    Andersen, Jessica
    Gerona-Navarro, Guillermo
    PROTEIN AND PEPTIDE LETTERS, 2018, 25 (12): : 1076 - 1089